Common Names: myrobalan
Study investigated antibacterial, antifungal, & anticancer effects of methanolic tuber extracts. Extracts showed cytotoxic effects on oral cancer cells, antioxidant & anti-inflammatory activities, and significant antibacterial effects. Potential therapeutic & commercial value, more research needed on active components and mechanisms.
Researchers investigated the link between type 2 diabetes and cardiovascular disease, finding common risk factors and proposing natural supplement treatment. This could be a promising preventive and therapeutic option for both diseases.
Nanoparticles loaded with Triphala (nanotriphala) show promise as a anti-inflammatory therapy for COVID-19. Chebulagic acid and chebulinic acid are the active compounds reducing cytokine release and inflammation.
Terminalia chebula reduces cognitive abnormalities from chronic stress by improving memory, synaptic density, and antioxidant levels in the brain. This suggests potential neuroprotective effects of Terminalia chebula in stress-induced conditions.
Various medicinal plants show promising anticancer activity against HER2-positive breast cancer cells by reducing HER2 expression, altering proteome profile, and containing multiple anticancer compounds. Potential innovative therapies for HER2-positive breast cancer.
The study found that the ethanolic Terminalia chebula extract reduced oxidative stress, improved brain integrity, and decreased abnormal changes in the brains of diabetic rats. This suggests that T. chebula extract could potentially be beneficial for the treatment of diabetes-related neuroinflammation.
BHQJ is a traditional Chinese herbal remedy made from 7 plants. It effectively treats cough asthma and reduces airway inflammation.
Researchers analyzed four medicinal plants and found that Plant A's methanol extract was most effective against α-amylase, while Plant B's water fraction showed strong α-glucosidase inhibition. Metabolic profiling revealed 32 secondary metabolites, with 22 tentatively identified.
Terminalia chebula fruit extract (TCF) shows potential as a targeted therapy for breast cancer, with antiproliferative effects and induction of apoptosis. Saccharopine, a phytochemical in TCF, has a higher binding affinity with EGFR. Promising for developing novel anticancer agents from plants.
T. chebula and chebulinic acid have multiple medicinal properties, including antimicrobial, antioxidant, anti-inflammatory, and hepatoprotective effects. They have potential use in treating various diseases and may be beneficial for general health and disease prevention.
Four ellagitannins from Terminalia chebula fruits inhibit acetylcholinesterase (AChE), a target for Alzheimer's treatment. They cause structural changes in AChE, making them potential natural inhibitors for Alzheimer's.
The herb Commiphora mukul has been used for centuries to treat various health conditions. It has potential medicinal and commercial value and should be studied more.
Alzheimer's disease is currently treated with acetylcholinesterase inhibitors (AChEIs) and NMDA receptor antagonists, which have drawbacks. A medicinal plant called Terminalia chebula has been studied for its potential as a therapeutic alternative due to its biochemicals, including hydrolysable tannins, phenolic compounds, and flavonoids. The use of this plant was reviewed in various databases, and it was found that T. chebula extracts and its constituents have AChEI and antioxidant and anti-inflammatory effects, all of which are relevant to the treatment of Alzheimer's disease.